# Meeting ç¸½çµè¨˜éŒ„ (Meeting 1-16)

**å°ˆæ¡ˆåç¨±**: RiskPrediction-3H
**ç ”ç©¶ç”Ÿ**: ç´€ä¼¯å–¬ (å­¸è™Ÿ: 21138X006)
**æŒ‡å°æ•™æˆ**: è¨±æšæ•™æˆ
**ç ”ç©¶ä¸»é¡Œ**: å¯è§£é‡‹èˆ‡é»‘ç›’æ¨¡å‹åœ¨ä¸‰é«˜ç–¾ç—…é æ¸¬ä¸Šçš„å¯¦è­‰æ¯”è¼ƒ

---

## ğŸ“… Meeting æ™‚é–“è»¸æ¦‚è¦½

### Phase 1: å°ˆæ¡ˆå¥ åŸºæœŸ (Meeting 01-03)
- **æ™‚é–“**: 2024å¹´12æœˆ - 2025å¹´1æœˆ
- **ä¸»é¡Œ**: å°ˆæ¡ˆæ¶æ§‹å»ºç«‹ã€é ˜åŸŸçŸ¥è­˜ç ”ç©¶
- **é‡Œç¨‹ç¢‘**: å®Œæˆå°ˆæ¡ˆåˆå§‹åŒ–ã€ç¢ºç«‹ç ”ç©¶æ–¹å‘

### Phase 2: æ–¹æ³•è«–è¨­è¨ˆæœŸ (Meeting 04-06)
- **æ™‚é–“**: 2025å¹´2-4æœˆ
- **ä¸»é¡Œ**: ç ”ç©¶æ–¹æ³•è«–å»ºç«‹ã€æ–‡ç»å›é¡§ç­–ç•¥
- **é‡Œç¨‹ç¢‘**: å»ºç«‹7éšæ®µç³»çµ±æ€§ç ”ç©¶æµç¨‹

### Phase 3: å¯¦é©—è¨­è¨ˆå„ªåŒ–æœŸ (Meeting 07-10)
- **æ™‚é–“**: 2025å¹´5-7æœˆ
- **ä¸»é¡Œ**: è³‡æ–™é›†ç­–ç•¥é‡å¤§èª¿æ•´
- **é‡Œç¨‹ç¢‘**: å¾å–®ä¸€è³‡æ–™é›†è½‰ç‚ºå¤šè³‡æ–™é›†æ¯”è¼ƒé©—è­‰

### Phase 4: æ¨¡å‹å¯¦é©—æœŸ (Meeting 11-13)
- **æ™‚é–“**: 2025å¹´8-9æœˆ
- **ä¸»é¡Œ**: æ¨¡å‹æ¯”è¼ƒèˆ‡å¯¦é©—åŸ·è¡Œ
- **é‡Œç¨‹ç¢‘**: å®Œæˆåˆæ­¥æ¨¡å‹å¯¦ä½œèˆ‡åˆ†æ

### Phase 5: æ–‡ç»æ·±åº¦è§£ææœŸ (Meeting 14-16)
- **æ™‚é–“**: 2025å¹´ä¸‹åŠå¹´
- **ä¸»é¡Œ**: å°ç£æ–‡ç»æ·±åº¦å›é¡§ã€å¤šä»»å‹™å­¸ç¿’ç ”ç©¶
- **é‡Œç¨‹ç¢‘**: ç³»çµ±æ€§æ–‡ç»å›é¡§ã€Taiwan MTLè«–æ–‡åˆ†æ

---

## ğŸ“ å„æ¬¡ Meeting è©³ç´°è¨˜éŒ„

### Meeting 01 - å°ˆæ¡ˆå•Ÿå‹•
**æª”æ¡ˆ**: [meeting01_21138X006_ç´€ä¼¯å–¬.pptx](meeting01_21138X006_ç´€ä¼¯å–¬.pptx)

**ä¸»é¡Œ**: å°ˆæ¡ˆåˆå§‹åŒ–èˆ‡ç ”ç©¶æ–¹å‘ç¢ºç«‹

**é‡é»å…§å®¹**:
- âœ… ç¢ºç«‹ç ”ç©¶ä¸»é¡Œï¼šä¸‰é«˜ç–¾ç—…é¢¨éšªé æ¸¬
- âœ… å»ºç«‹å®Œæ•´å°ˆæ¡ˆæ¶æ§‹ (RiskPrediction-3H)
- âœ… åˆå§‹è³‡æ–™é›†ï¼šSUA_CVDs_risk_factors.csv (25,744ç­†)
- âœ… è¨­å®š Git ç‰ˆæœ¬æ§åˆ¶ç³»çµ±

**é—œéµæ±ºç­–**:
- ç ”ç©¶ç›®æ¨™ï¼šæ¯”è¼ƒå¯è§£é‡‹ vs é»‘ç›’æ¨¡å‹
- ç›®æ¨™ç–¾ç—…ï¼šé«˜è¡€å£“ã€é«˜è¡€ç³–ã€é«˜è¡€è„‚

**è³‡æ–™é›†ä¾†æº**:
- DOI: [10.5061/dryad.z08kprrk1](https://datadryad.org/dataset/doi%3A10.5061/dryad.z08kprrk1)
- æè¿°ï¼šä¸­åœ‹æ±å—éƒ¨ç¤¾å€èª¿æŸ¥æ•¸æ“šï¼ˆ2010-2018ï¼‰

---

### Meeting 02-03 - Domain Knowledge æ·±åº¦ç ”ç©¶
**æª”æ¡ˆ**:
- [meeting02_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting02_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting03_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting03_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [2025-01-08_domain_knowledge_prep.md](2025-01-08_domain_knowledge_prep.md)

**ä¸»é¡Œ**: ä¸‰é«˜é ˜åŸŸçŸ¥è­˜é«”ç³»å»ºç«‹

**6å¤§æ¶æ§‹ç ”ç©¶è¨ˆç•«**:
1. åŸºç¤å®šç¾© & è‡¨åºŠè¨ºæ–·æ¨™æº–
2. ä¸‰é«˜çš„æµè¡Œç—…å­¸èƒŒæ™¯
3. è‡¨åºŠèˆ‡ç”Ÿç†é—œè¯
4. è³‡æ–™ä¾†æºèˆ‡å¸¸è¦‹æŒ‡æ¨™
5. ç ”ç©¶æ–¹æ³• & æ‡‰ç”¨å ´æ™¯
6. çˆ­è­°èˆ‡ç ”ç©¶ç©ºç™½

**å°ˆå®¶è«®è©¢**:
- æ—¥æœŸï¼š2025/01/08ï¼ˆé€±ä¸‰ï¼‰
- å°è±¡ï¼šé†«å¸«
- ç›®çš„ï¼šè¨è«–ä¸‰é«˜ç–¾ç—…çš„ domain knowledge

**é—œéµæ´å¯Ÿ**:
- äº†è§£è¨ºæ–· cutoff å€¼æ˜¯åšä»»ä½•æ¨™è¨»/åˆ†é¡çš„åŸºç¤
- é«˜è¡€å£“ï¼šâ‰¥140/90 mmHg
- é«˜è¡€ç³–ï¼šç©ºè…¹è¡€ç³– â‰¥126 mg/dL, HbA1c â‰¥6.5%
- é«˜è¡€è„‚ï¼šé«˜ LDL-C, é«˜ TG, ä½ HDL

---

### Meeting 04-06 - ç ”ç©¶æ–¹æ³•è«–å»ºç«‹
**æª”æ¡ˆ**:
- [meeting04_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting04_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting05_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting05_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting05.docx](meeting05.docx)
- [meeting06_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting06_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)

**ä¸»é¡Œ**: 7éšæ®µç³»çµ±æ€§ç ”ç©¶æµç¨‹è¨­è¨ˆ

**ç ”ç©¶æµç¨‹**:
1. **Literature Review** (2-4é€±)
2. **Research Question & Hypothesis** (1é€±)
3. **Data Collection & Understanding** (1-2é€±)
4. **Methodology Design** (1-2é€±)
5. **Experiments** (3-4é€±)
6. **Analysis & Results** (2-3é€±)
7. **Paper Writing** (4-6é€±)

**è«–æ–‡å¯«ä½œé †åº**:
- Methods â†’ Results â†’ Discussion â†’ Introduction â†’ Abstract

**é ä¼°ç¸½ç ”ç©¶æ™‚é–“**:
- 22é€± (ç´„5-6å€‹æœˆ)

**é—œéµå­¸ç¿’**:
- å…ˆè¦åŠƒå¾ŒåŸ·è¡Œï¼Œé¿å…ç›²ç›®å¯¦é©—
- ç³»çµ±æ€§æ–¹æ³•ç¢ºä¿ç ”ç©¶å®Œæ•´æ€§

---

### Meeting 07-10 - è³‡æ–™é›†ç­–ç•¥é‡å¤§èª¿æ•´
**æª”æ¡ˆ**:
- [meeting07_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting07_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting08_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting08_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting09_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting09_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting10_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting10_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting10_Dataset.txt](meeting10_Dataset.txt)

**ä¸»é¡Œ**: å¾å–®ä¸€è³‡æ–™é›†è½‰ç‚ºå¤šè³‡æ–™é›†æ¯”è¼ƒé©—è­‰

**ç­–ç•¥èª¿æ•´**:

**åŸå§‹è¨ˆç•«**:
- å–®ä¸€å¤§å‹å¿ƒè¡€ç®¡è³‡æ–™é›† (25,744ç­†)
- å°ˆæ³¨ä¸‰é«˜ç–¾ç—…é æ¸¬

**èª¿æ•´å¾Œç­–ç•¥**:
- å¤šå€‹æ¨™æº–é†«å­¸è³‡æ–™é›†é©—è­‰
- æ“´å±•åˆ°ä¸åŒé†«å­¸é æ¸¬ä»»å‹™
- æå‡æ¨¡å‹é€šç”¨æ€§é©—è­‰

**æ–°å¢4å€‹æ¨™æº–è³‡æ–™é›†**:

1. **Chronic Kidney Disease (CKD)**
   - é€£çµ: https://archive.ics.uci.edu/ml/datasets/chronic_kidney_disease
   - è³‡æ–™ç­†æ•¸ï¼š400
   - é¡åˆ¥ï¼šCKD / not CKDï¼ˆä¸å¹³è¡¡æ¯”ç´„ 27:73ï¼‰

2. **Fertility Diagnosis**
   - é€£çµ: https://archive.ics.uci.edu/ml/datasets/Fertility
   - è³‡æ–™ç­†æ•¸ï¼š100
   - é¡åˆ¥ï¼šNï¼ˆæ­£å¸¸ï¼‰/ Oï¼ˆç•°å¸¸ï¼‰ï¼Œä¸å¹³è¡¡æ¯”ç´„ 88:12

3. **Wisconsin Diagnostic Breast Cancer (WDBC)**
   - é€£çµ: https://archive.ics.uci.edu/ml/datasets/Breast+Cancer+Wisconsin+(Diagnostic)
   - è³‡æ–™ç­†æ•¸ï¼š569
   - é¡åˆ¥ï¼šBenign / Malignantï¼ˆè‰¯æ€§ / æƒ¡æ€§ï¼‰

4. **BUPA Liver Disorders**
   - é€£çµ: https://archive.ics.uci.edu/ml/datasets/liver+disorders
   - è³‡æ–™ç­†æ•¸ï¼š345
   - é¡åˆ¥ï¼šæœ‰è‚ç—… / ç„¡è‚ç—…

**æ±ºç­–ç†ç”±**:
1. å¢å¼·ç ”ç©¶çµè«–çš„å»£æ³›é©ç”¨æ€§
2. ä½¿ç”¨æ¨™æº–benchmarkè³‡æ–™é›†ä¾¿æ–¼æ¯”è¼ƒ
3. é¿å…å–®ä¸€è³‡æ–™é›†çš„ç‰¹æ®Šæ€§é™åˆ¶
4. æå‡è«–æ–‡ç™¼è¡¨ç«¶çˆ­åŠ›

---

### Meeting 11-13 - æ¨¡å‹æ¯”è¼ƒèˆ‡å¯¦é©—
**æª”æ¡ˆ**:
- [meeting11_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting11_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting12_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting12_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting13_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting13_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)

**ä¸»é¡Œ**: æ¨¡å‹å¯¦ä½œèˆ‡åˆæ­¥å¯¦é©—

**å¯¦é©—å…§å®¹**:
- âœ… æ¨¡å‹å¯¦ä½œèˆ‡è¨“ç·´
- âœ… äº¤å‰é©—è­‰ç­–ç•¥åŸ·è¡Œ
- âœ… æ•ˆèƒ½æŒ‡æ¨™åˆ†æï¼šAccuracy, Precision, Recall, F1-score, ROC-AUC
- âœ… SHAPè§£é‡‹æ€§åˆ†æ

**æ¨¡å‹æ¯”è¼ƒ**:
- **å¯è§£é‡‹æ¨¡å‹**: Logistic Regression, Decision Tree
- **é»‘ç›’æ¨¡å‹**: Random Forest, SVM, Neural Networks

**è©•ä¼°æŒ‡æ¨™**:
- ä¸»è¦ï¼šAUC-ROC, F1-Score, Recall
- æ¬¡è¦ï¼šPrecision, Specificity, NPV/PPV

---

### Meeting 14 - å°ç£æ–‡ç»å›é¡§ç­–ç•¥
**æª”æ¡ˆ**: [meeting14_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting14_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)

**ä¸»é¡Œ**: å°ç£ä¸‰é«˜æ–‡ç»ç³»çµ±æ€§å›é¡§

**ä»»å‹™ç›®æ¨™**:
- **Q1**: å®Œæˆå°ç£ä¸‰é«˜æ–‡ç»å›é¡§ï¼ˆæ‰¾åˆ° 10 ç¯‡ç›¸é—œç ”ç©¶ï¼‰
- **Q2**: é æ¸¬è¦æ ¼å®šç¾©
- **Q3**: è³‡æ–™é›†é¸æ“‡

**æ–‡ç»æœå°‹ç¯„åœ**:
- åœ°å€ï¼šå°ç£åŠè¯äººåœ°å€
- é—œéµå­—ï¼šæ©Ÿå™¨å­¸ç¿’ã€é«˜è¡€å£“ã€ç³–å°¿ç—…ã€é«˜è¡€è„‚ã€ä»£è¬ç—‡å€™ç¾¤
- æ™‚é–“ç¯„åœï¼š2010-2025

**æ–‡ç»åˆ†é¡**:
- å–®ä¸€ç–¾ç—…é æ¸¬ï¼š6ç¯‡ï¼ˆé«˜è¡€å£“ 2ç¯‡ã€ç³–å°¿ç—… 3ç¯‡ã€ä»£è¬ç—‡å€™ç¾¤ 3ç¯‡ï¼‰
- **å¤šç–¾ç—…åŒæ™‚é æ¸¬ï¼š3ç¯‡**ï¼ˆé‡é»é—œæ³¨ï¼‰

---

### Meeting 15 - ç ”ç©¶é€²åº¦å ±å‘Šèˆ‡é æ¸¬è¦æ ¼å®šç¾©
**æª”æ¡ˆ**:
- [meeting15_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting15_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting15_presentation_outline.md](meeting15_presentation_outline.md)

**ä¸»é¡Œ**: ä¸‰é«˜é¢¨éšªé æ¸¬ç ”ç©¶é€²åº¦å ±å‘Šï¼ˆ20åˆ†é˜ï¼Œ18é ï¼‰

**ç°¡å ±çµæ§‹**:

#### ç¬¬ä¸€éƒ¨åˆ†ï¼šé–‹å ´èˆ‡ç›®æ¨™å›é¡§ï¼ˆ2é ï¼‰
- Meeting 14 ä»»å‹™å›é¡§
- æœ¬æ¬¡é‡é»ï¼šå¤šç–¾ç—…åŒæ™‚é æ¸¬

#### ç¬¬äºŒéƒ¨åˆ†ï¼šQ1 å°ç£ä¸‰é«˜æ–‡ç»å›é¡§ï¼ˆ4é ï¼‰
- æ–‡ç»æœå°‹ç­–ç•¥
- ğŸ¯ **çªç ´æ€§ç™¼ç¾**ï¼šTaiwan MTL (2025) - åŒæ™‚é æ¸¬4ç¨®ç–¾ç—…
- å…¶ä»–å¤šç–¾ç—…é æ¸¬ç ”ç©¶
- æ–‡ç»å›é¡§ç¸½çµèˆ‡ Benchmark

#### ç¬¬ä¸‰éƒ¨åˆ†ï¼šQ2 é æ¸¬è¦æ ¼å®šç¾©ï¼ˆ5é ï¼‰
- ç ”ç©¶å•é¡Œå®šç¾©ï¼šä½¿ç”¨å‰å…©æ¬¡å¥åº·æª¢æŸ¥è³‡æ–™ï¼Œé æ¸¬ç¬¬ä¸‰æ¬¡æª¢æŸ¥çš„ä¸‰é«˜é¢¨éšª
- **è¼¸å…¥ç‰¹å¾µè¨­è¨ˆ**ï¼ˆ28å€‹ç‰¹å¾µï¼‰ï¼š
  - Tâ‚ ç‰¹å¾µï¼ˆç¬¬ä¸€æ¬¡æª¢æŸ¥ï¼‰
  - Tâ‚‚ ç‰¹å¾µï¼ˆç¬¬äºŒæ¬¡æª¢æŸ¥ï¼‰
  - Î” è®ŠåŒ–é‡ç‰¹å¾µ
  - æ™‚é–“ç‰¹å¾µ
- è¼¸å‡ºèˆ‡è¨ºæ–·æ¨™æº–
- è©•ä¼°æŒ‡æ¨™
- è³‡æ–™åˆ†å‰²ç­–ç•¥

#### ç¬¬å››éƒ¨åˆ†ï¼šQ3 è³‡æ–™é›†é¸æ“‡ï¼ˆ3é ï¼‰
- è³‡æ–™é›†æ¢ç´¢æ­·ç¨‹ï¼šHRS 2016 â†’ NHANES â†’ Synthea
- Synthea è³‡æ–™é›†ç‰¹æ€§
- è³‡æ–™è½‰æ›èˆ‡é è™•ç†

#### ç¬¬äº”éƒ¨åˆ†ï¼šèˆ‡æ–‡ç»å°æ¯”èˆ‡ç ”ç©¶å„ªå‹¢ï¼ˆ2é ï¼‰
- æœ¬ç ”ç©¶ vs. ç¾æœ‰æ–‡ç»
- ç ”ç©¶ç¼ºå£ï¼ˆResearch Gapï¼‰
- ä¸‹ä¸€æ­¥è¨ˆåŠƒèˆ‡æ™‚ç¨‹

**å°ç£ç ”ç©¶æ€§èƒ½åŸºæº–**:
| ç–¾ç—… | AUC ç¯„åœ | æº–ç¢ºç‡ |
|------|---------|--------|
| é«˜è¡€å£“ | 0.75-0.85 | - |
| ç³–å°¿ç—… | 0.76-0.99 | 98-99% |
| ä»£è¬ç—‡å€™ç¾¤ | 0.90-0.93 | - |

**æœ¬ç ”ç©¶ç›®æ¨™**:
- AUC-ROC > 0.75
- F1-Score > 0.65
- Recall > 0.65

---

### Meeting 16 - Taiwan MTL (2025) è«–æ–‡æ·±åº¦è§£æ
**æª”æ¡ˆ**:
- [meeting16_21138X006_ç´€ä¼¯å–¬_wVBA.pptm](meeting16_21138X006_ç´€ä¼¯å–¬_wVBA.pptm)
- [meeting16_taiwan_mtl_presentation_outline.md](meeting16_taiwan_mtl_presentation_outline.md)
- [meeting16_taiwan_mtl_presentation_outline_10min.md](meeting16_taiwan_mtl_presentation_outline_10min.md)

**ä¸»é¡Œ**: Multitask learning multimodal network for chronic disease prediction

**è«–æ–‡è³‡è¨Š**:
- **æ¨™é¡Œ**: Multitask learning multimodal network for chronic disease prediction
- **æœŸåˆŠ**: Scientific Reports (2025å¹´5æœˆ) - **SCI æœŸåˆŠ** (IF ~4.0, Q2)
- **ä½œè€…**: Tsai et al. (å°å¤§è³‡å·¥ç³» Ã— é•·åºšé†«é™¢ Ã— åœ‹å®¶å¤ªç©ºä¸­å¿ƒ)
- **DOI**: [10.1038/s41598-025-99554-z](https://doi.org/10.1038/s41598-025-99554-z)
- **PDFä½ç½®**: [docs/references/s41598-025-99554-z.pdf](../references/s41598-025-99554-z.pdf)
- **ä¸­æ–‡ç¿»è­¯**: [Taiwan_MTL_2025_ä¸­æ–‡ç¿»è­¯.md](../references/Taiwan_MTL_2025_ä¸­æ–‡ç¿»è­¯.md)

**ç°¡å ±æ¶æ§‹**ï¼ˆ10åˆ†é˜ç²¾ç°¡ç‰ˆï¼‰:

#### Slide 1-2: ç ”ç©¶å‹•æ©Ÿ
- **å‚³çµ±å•é¡Œ**: é æ¸¬ä¸åŒç–¾ç—…éœ€ç¨ç«‹æ¨¡å‹ â†’ è€—æ™‚è€—è³‡æº
- **ç ”ç©¶ç›®æ¨™**: ä½¿ç”¨ MTL åŒæ™‚é æ¸¬ 4 ç¨®æ…¢æ€§ç—…
  - ç³–å°¿ç—… (22.4%)
  - å¿ƒè‡Ÿç—… (24.6%)
  - ä¸­é¢¨ (8.7%)
  - é«˜è¡€å£“ (39.0%)

#### Slide 3: è³‡æ–™èˆ‡ä»»å‹™
- **é æ¸¬ä»»å‹™**: éå» 10 å¹´é†«ç™‚ç´€éŒ„ â†’ é æ¸¬æœªä¾† 5 å¹´ç–¾ç—…é¢¨éšª
- **è³‡æ–™ä¾†æº**: å°ç£ HWDCï¼ˆå¥åº·èˆ‡ç¦åˆ©è³‡æ–™ç§‘å­¸ä¸­å¿ƒï¼‰
  - 200è¬äººæ¨£æœ¬
  - æœ€çµ‚ï¼š555,124 æ¨£æœ¬
- **è¼¸å…¥ç‰¹å¾µ**:
  - 180 å€‹ ICD codesï¼ˆWord2Vec Embeddingï¼‰
  - å€‹äººè³‡è¨Šï¼ˆå¹´é½¡ã€æ€§åˆ¥ã€å±…ä½åœ°ã€è·æ¥­ï¼‰

#### Slide 4: MTL æ¨¡å‹æ¶æ§‹
- **æ ¸å¿ƒå‰µæ–°**: Multi-Task Learning (MTL)
  - STLï¼š4å€‹ç¨ç«‹æ¨¡å‹ï¼Œ4å€åƒæ•¸é‡
  - MTLï¼š1å€‹å…±äº«æ¨¡å‹ï¼Œåƒ…éœ€ 1/4 åƒæ•¸
- **æ¨¡å‹çµ„æˆ**:
  - ICD Embedding (Word2Vec)
  - ICD Extraction Module (LSTM æœ€ä½³)
  - Hard Parameter Sharing
  - 4å€‹ç¨ç«‹é æ¸¬å±¤

#### Slide 5-6: æ•ˆèƒ½èˆ‡åƒæ•¸æ•ˆç‡
**MTL vs STLï¼ˆMAND-LSTMï¼‰**:
| ç–¾ç—… | STL AUC | MTL AUC |
|------|---------|---------|
| é«˜è¡€å£“ | 0.9346 | 0.9346 |
| ç³–å°¿ç—… | 0.8926 | 0.8912 |
| å¿ƒè‡Ÿç—… | 0.8774 | 0.8787 âœ¨ |
| ä¸­é¢¨ | 0.8700 | 0.8625 |

**åƒæ•¸æ•ˆç‡**:
- 4å€‹ STLï¼š1,608,468 åƒæ•¸
- 1å€‹ MTLï¼š419,784 åƒæ•¸ â­ï¼ˆåƒ…éœ€ 1/4ï¼‰

#### Slide 7-8: ç‰¹å¾µé‡è¦æ€§èˆ‡é¢¨éšªå› å­
**å€‹äººè³‡è¨Šé‡è¦æ€§**:
- **å¹´é½¡** â†’ AUC ä¸‹é™æœ€å¤šï¼ˆ-0.054ï¼‰â­
- æ€§åˆ¥ã€å±…ä½åœ°å€ï¼šæ¬¡è¦å½±éŸ¿

**Attention Score åˆ†æ**ï¼ˆå‰2000é«˜é¢¨éšªæ‚£è€…ï¼‰:
1. **å¯ä¿®æ”¹å› å­**: é«˜è¡€è„‚ (272.0, 272.2, 272.4)
2. **å¤šé‡æ…¢æ€§ç—…**: ç—›é¢¨ã€ç™½å…§éšœã€æ…¢æ€§è‚ç‚ã€è…è¡°ç«­
3. **æ–°èˆˆå› å­**: ç„¦æ…®ç—‡ã€æ†‚é¬±ç—‡

#### Slide 9: ç ”ç©¶è²¢ç»
**5å¤§è²¢ç»**:
1. âœ… è­‰æ˜ MTL å¯åŒæ™‚é æ¸¬å¤šç¨®æ…¢æ€§ç—…
2. âœ… Word2Vec Embedding æœ‰æ•ˆæ•æ‰ç–¾ç—…é—œè¯
3. âœ… åƒæ•¸æ•ˆç‡ï¼š1/4 åƒæ•¸é”ç›¸åŒæ•ˆèƒ½
4. âœ… é«˜å¯è§£é‡‹æ€§ï¼šé¢¨éšªå› å­ç¬¦åˆæ–‡ç»
5. âœ… é«˜ç©©å¥æ€§ï¼š60% ç´€éŒ„é®è”½ä»ç¶­æŒæ•ˆèƒ½

**èˆ‡æœ¬ç ”ç©¶é—œè¯**:
- Taiwan MTLï¼š4 ç¨®ç–¾ç—…ï¼ˆç³–å°¿ç—…ã€é«˜è¡€å£“ã€å¿ƒè‡Ÿç—…ã€ä¸­é¢¨ï¼‰
- æœ¬ç ”ç©¶ï¼š3 ç¨®ç–¾ç—…ï¼ˆé«˜è¡€å£“ã€é«˜è¡€ç³–ã€é«˜è¡€è„‚ï¼‰
- å¯åƒè€ƒï¼šICD embedding + Attention æ©Ÿåˆ¶

#### Slide 10: é™åˆ¶èˆ‡å•Ÿç™¼
**ç ”ç©¶é™åˆ¶**:
- âš ï¸ è³‡æ–™ä¸å¹³è¡¡ â†’ ä¸­é¢¨ FNR é«˜
- âš ï¸ ä¾è³´ 10 å¹´å®Œæ•´é†«ç™‚ç´€éŒ„
- âš ï¸ Balanced Accuracy 60-80%ï¼ˆé©åˆè¼”åŠ©è¨ºæ–·ï¼‰

**å°æœ¬ç ”ç©¶çš„å•Ÿç™¼**:
1. å¯è€ƒæ…® MTL æ¡†æ¶
2. ä½¿ç”¨ Word2Vec è™•ç†ç–¾ç—…ä»£ç¢¼
3. Attention æ©Ÿåˆ¶æå‡å¯è§£é‡‹æ€§

**ç›¸é—œæ–‡æª”**:
- [Attention æ©Ÿåˆ¶æ‡‰ç”¨æŒ‡å—](../references/attention_mechanism_guide.md)
- [ç³»çµ±æ€§æ–‡ç»å›é¡§](../literature_notes/Systematic_Literature_Review.md)ï¼ˆTaiwan MTL åˆ—ç‚º Entry #16ï¼‰

---

## ğŸ“Š é‡è¦è«–æ–‡èˆ‡ DOI æ¸…å–®

### ä¸»è¦ç ”ç©¶è«–æ–‡ï¼ˆå·²è®€ï¼‰

#### 1. Taiwan MTL (2025) - å¤šä»»å‹™å­¸ç¿’é æ¸¬æ…¢æ€§ç—… â­â­â­â­â­
- **DOI**: [10.1038/s41598-025-99554-z](https://doi.org/10.1038/s41598-025-99554-z)
- **æœŸåˆŠ**: Scientific Reports (SCI, IF ~4.0)
- **æª”æ¡ˆ**: [s41598-025-99554-z.pdf](../references/s41598-025-99554-z.pdf)
- **å ±å‘Š**: Meeting 16
- **é‡è¦æ€§**: èˆ‡æœ¬ç ”ç©¶é«˜åº¦ç›¸é—œï¼Œå¤šç–¾ç—…åŒæ™‚é æ¸¬

#### 2. Liu et al. (2024) - å°ç£ç³–å°¿ç—… 10 å¹´é æ¸¬ â­â­â­â­â­
- **DOI**: [10.3390/diagnostics15010072](https://doi.org/10.3390/diagnostics15010072)
- **æœŸåˆŠ**: Diagnostics, 15(1), 72
- **æª”æ¡ˆ**: [diagnostics-15-00072.pdf](../references/diagnostics-15-00072.pdf)
- **å ±å‘Š**: Meeting 14-15ï¼ˆä¸‹æ¬¡é å‘Šï¼‰
- **é‡è¦æ€§**: å°ç£ç¬¬ä¸€å€‹ EHR + ML ç³–å°¿ç—…é æ¸¬ï¼Œ10å¹´è¿½è¹¤ï¼Œæº–ç¢ºç‡99%
- **æ·±åº¦è§£æ**: [Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md](../literature_notes/Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md)

#### 3. Hung et al. (2021) - å°ç£é«˜è¡€å£“é æ¸¬ â­â­â­â­â­
- **DOI**: [10.3389/fcvm.2021.778306](https://doi.org/10.3389/fcvm.2021.778306)
- **æœŸåˆŠ**: Frontiers in Cardiovascular Medicine, 8:778306
- **æª”æ¡ˆ**: [fcvm-08-778306.pdf](../references/fcvm-08-778306.pdf)
- **å ±å‘Š**: Meeting 14-15ï¼ˆä¸‹æ¬¡é å‘Šï¼‰
- **é‡è¦æ€§**: å°ç£å¤šä¸­å¿ƒç ”ç©¶ï¼Œå®Œæ•´çš„ ML pipeline èˆ‡å¤–éƒ¨é©—è­‰

#### 4. Lin et al. (2024) - å°¿é…¸æ§åˆ¶èˆ‡é«˜è¡€å£“é¢¨éšª âš ï¸ é—œè¯ç ”ç©¶ï¼ˆéé æ¸¬æ¨¡å‹ï¼‰
- **DOI**: [10.3389/fendo.2024.1343998](https://doi.org/10.3389/fendo.2024.1343998)
- **æœŸåˆŠ**: Frontiers in Endocrinology
- **æª”æ¡ˆ**: [fendo-15-1343998.pdf](../references/fendo-15-1343998.pdf)
- **è³‡æ–™ä¾†æº**: ä¸­åœ‹æ±å—éƒ¨ç¤¾å€èª¿æŸ¥ï¼ˆ2010-2018ï¼‰- **èˆ‡æœ¬ç ”ç©¶ä½¿ç”¨ç›¸åŒ Dataset**
- **ç ”ç©¶é¡å‹**: é—œè¯ç ”ç©¶ï¼ˆAssociation Studyï¼‰ï¼Œéé æ¸¬æ¨¡å‹ï¼ˆPrediction Modelï¼‰
- **åˆ†ææ–‡æª”**: [Why_Not_Extend_Lin_Guo_Studies.md](../Why_Not_Extend_Lin_Guo_Studies.md)

#### 5. Guo et al. (2025) - å°¿é…¸èˆ‡ç¸½è†½å›ºé†‡çš„åŠ‘é‡åæ‡‰é—œä¿‚
- **DOI**: [10.1177/03000605251318203](https://doi.org/10.1177/03000605251318203)
- **æœŸåˆŠ**: Journal of International Medical Research, 53(2), 1â€“15
- **æª”æ¡ˆ**: [guo-et-al-2025-the-dose-response-relationship...pdf](../references/)
- **è³‡æ–™ä¾†æº**: ä¸­åœ‹æ±å—éƒ¨ç¤¾å€èª¿æŸ¥ï¼ˆ2010-2018ï¼‰- **èˆ‡ Lin et al. ç›¸åŒæ•¸æ“šé›†**
- **ç ”ç©¶é¡å‹**: æ©«æ–·é¢ç ”ç©¶
- **æ¨£æœ¬æ•¸**: 6,119 ä½æˆäºº

### å¾…ç ”ç©¶è«–æ–‡

#### DHDIP (2022) - é«˜è¡€å£“èˆ‡é«˜è¡€è„‚è¯åˆé æ¸¬
- **æœŸåˆŠ**: Computer Methods and Programs in Biomedicine
- **é æ¸¬ç›®æ¨™**: åŒæ™‚é æ¸¬é«˜è¡€å£“å’Œé«˜è¡€è„‚
- **ç‰¹è‰²**: Multi-objective learning + é«˜å¯è§£é‡‹æ€§

#### Multi-Disease Prediction (2010) - å…±åŒé¢¨éšªå› å­
- **æœŸåˆŠ**: Expert Systems with Applications
- **é æ¸¬ç›®æ¨™**: åŒæ™‚é æ¸¬é«˜è¡€å£“å’Œé«˜è¡€è„‚
- **æ–¹æ³•**: å…©éšæ®µå¤šç–¾ç—…é æ¸¬ï¼ˆå…±åŒé¢¨éšªå› å­åˆ†æï¼‰

---

## ğŸ¯ ç ”ç©¶é€²å±•ç¸½çµ

### âœ… å·²å®Œæˆé …ç›®
- [x] å°ˆæ¡ˆæ¶æ§‹å»ºç«‹èˆ‡ç‰ˆæœ¬æ§åˆ¶
- [x] 6å¤§é ˜åŸŸçŸ¥è­˜æ¶æ§‹ç ”ç©¶
- [x] 7éšæ®µç ”ç©¶æ–¹æ³•è«–è¨­è¨ˆ
- [x] å¤šè³‡æ–™é›†é¸æ“‡èˆ‡æ–‡æª”åŒ–ï¼ˆ5å€‹è³‡æ–™é›†ï¼‰
- [x] 16æ¬¡æ­£å¼ advisor meeting
- [x] è‡¨åºŠå°ˆå®¶è«®è©¢èˆ‡é©—è­‰ï¼ˆ2025/01/08ï¼‰
- [x] ç³»çµ±æ€§æ–‡ç»å›é¡§ï¼ˆ16+ ç¯‡è«–æ–‡ï¼‰
- [x] Taiwan MTL (2025) æ·±åº¦è§£æ

### ğŸ”„ é€²è¡Œä¸­é …ç›®
- [ ] Literature Review æ·±åŒ–ï¼ˆStage 1/7ï¼‰
- [ ] æ¨¡å‹å¯¦é©—èˆ‡æ¯”è¼ƒåˆ†æ
- [ ] SHAP è§£é‡‹æ€§åˆ†æ
- [ ] çµ±è¨ˆé¡¯è‘—æ€§æª¢é©—

### ğŸ“‹ å¾…åŸ·è¡Œé …ç›®
- [ ] Research Question å…·é«”åŒ–ï¼ˆStage 2ï¼‰
- [ ] è³‡æ–™æ¢ç´¢èˆ‡å‰è™•ç†ï¼ˆStage 3ï¼‰
- [ ] å®Œæ•´å¯¦é©—åŸ·è¡Œï¼ˆStage 5ï¼‰
- [ ] çµæœåˆ†æèˆ‡è¨è«–ï¼ˆStage 6ï¼‰
- [ ] è«–æ–‡æ’°å¯«ï¼ˆStage 7ï¼‰

---

## ğŸ“š é—œéµæ–‡æª”ç´¢å¼•

### Meeting è¨˜éŒ„
- [Meeting 01-16 ç°¡å ±](.) - æ‰€æœ‰ .pptx / .pptm æª”æ¡ˆ
- [Meeting 15 ç°¡å ±å¤§ç¶±](meeting15_presentation_outline.md)
- [Meeting 16 ç°¡å ±å¤§ç¶±ï¼ˆ10åˆ†é˜ï¼‰](meeting16_taiwan_mtl_presentation_outline_10min.md)
- [Domain Knowledge æº–å‚™](2025-01-08_domain_knowledge_prep.md)

### æ–‡ç»å›é¡§
- [ç³»çµ±æ€§æ–‡ç»å›é¡§](../literature_notes/Systematic_Literature_Review.md) - 16+ ç¯‡è«–æ–‡
- [Liu 2024 æ·±åº¦è§£æ](../literature_notes/Liu_2024_TCVGH_Diabetes_Prediction_æ·±åº¦è§£æ.md)
- [Taiwan MTL ä¸­æ–‡ç¿»è­¯](../references/Taiwan_MTL_2025_ä¸­æ–‡ç¿»è­¯.md)
- [åƒè€ƒæ–‡ç»æ¸…å–®](../references/README.md)

### æ–¹æ³•è«–èˆ‡æ¦‚å¿µ
- [ç ”ç©¶æ–¹æ³•è«–æŒ‡å—](../research_methodology_guide.md)
- [AUC-ROC è©³ç´°èªªæ˜](../concepts/AUC-ROC_è©³ç´°èªªæ˜.md)
- [äº¤å‰é©—è­‰](../concepts/Cross_Validation.md)
- [é¡åˆ¥ä¸å¹³è¡¡è™•ç†](../concepts/Class_Imbalance_in_Medical_Prediction.md)
- [Attention æ©Ÿåˆ¶æ‡‰ç”¨æŒ‡å—](../references/attention_mechanism_guide.md)

### ç ”ç©¶åˆ†æ
- [ç‚ºä½•ä¸å»¶ä¼¸ Lin/Guo ç ”ç©¶](../Why_Not_Extend_Lin_Guo_Studies.md)
- [ç‚ºä½•å¤šå› å­é æ¸¬é‡è¦](../Why_Multifactor_Prediction_Matters.md)

### é€²åº¦è¿½è¹¤
- [å·¥ä½œæ—¥èªŒ](../work_journal.md)
- [ç ”ç©¶æ­·ç¨‹](../research_journey.md)

---

## ğŸ’¡ é—œéµæ´å¯Ÿèˆ‡å­¸ç¿’

### æˆåŠŸç¶“é©—
1. **ç³»çµ±æ€§æ–¹æ³•**: 6å¤§é ˜åŸŸçŸ¥è­˜æ¶æ§‹ + 7éšæ®µç ”ç©¶æµç¨‹ç¢ºä¿å®Œæ•´æ€§
2. **å°ˆå®¶è«®è©¢**: è‡¨åºŠé†«å¸«åƒèˆ‡æå‡ç ”ç©¶å“è³ª
3. **æ–‡æª”ç®¡ç†**: å®Œæ•´ç‰ˆæœ¬æ§åˆ¶èˆ‡é€²åº¦è¿½è¹¤
4. **æŒçºŒæºé€š**: å®šæœŸ advisor meeting ç¢ºä¿æ–¹å‘æ­£ç¢º

### é‡å¤§è½‰æŠ˜é»
1. **Meeting 10**: å¾å–®ä¸€è³‡æ–™é›†è½‰ç‚ºå¤šè³‡æ–™é›†é©—è­‰ç­–ç•¥
2. **Meeting 15**: ç™¼ç¾ Taiwan MTL å¤šç–¾ç—…é æ¸¬ç ”ç©¶
3. **Meeting 16**: æ·±åº¦è§£æ MTL æ¶æ§‹ï¼Œç‚ºæœ¬ç ”ç©¶æ‰¾åˆ°æ–°æ–¹å‘

### ç ”ç©¶å‰µæ–°é»
1. **ç¸±å‘æ™‚åºé æ¸¬**: Tâ‚â†’Tâ‚‚â†’Tâ‚ƒ çš„å‹•æ…‹è®ŠåŒ–ï¼ˆÎ” ç‰¹å¾µï¼‰
2. **å¤šæ¨™ç±¤åŒæ™‚é æ¸¬**: ä¸‰é«˜ç¶œåˆè©•ä¼°
3. **å¯è§£é‡‹æ€§æ¬Šè¡¡**: æº–ç¢ºæ€§ vs å¯è§£é‡‹æ€§çš„å¯¦è­‰æ¯”è¼ƒ
4. **å¤šè³‡æ–™é›†é©—è­‰**: æå‡æ¨¡å‹é€šç”¨æ€§

---

**æ–‡æª”å»ºç«‹æ—¥æœŸ**: 2025å¹´ï¼ˆåŸºæ–¼ Meeting 1-16 è¨˜éŒ„å½™æ•´ï¼‰
**æœ€å¾Œæ›´æ–°**: 2025å¹´
**ä¸‹ä¸€æ¬¡ Meeting**: å¾…å®š

---

## ğŸ“Œ å¿«é€Ÿå°èˆª

- ğŸ“‚ [è¿”å› Meeting Notes ç›®éŒ„](.)
- ğŸ“– [æŸ¥çœ‹ç³»çµ±æ€§æ–‡ç»å›é¡§](../literature_notes/Systematic_Literature_Review.md)
- ğŸ“Š [æŸ¥çœ‹ç ”ç©¶æ­·ç¨‹](../research_journey.md)
- ğŸ¯ [æŸ¥çœ‹å°ˆæ¡ˆ README](../../README.md)
